GlassScriptPhysician profile
Lori A Tucker
NPI 1174534291
$45,532.77
in general payments reported to CMS, 2019-2025
20 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $920 · 2020: $55.11 · 2021: $39K · 2022: $5,242 · 2023: $235 · 2024: $351 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $708.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $708.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $43,801.25 | 2020-2022 | |
| Boston Scientific Corporation | $761.60 | 2019 | |
| Novo Nordisk INC | $172.21 | 2023-2024 | Wegovy |
| Abbvie INC. | $156.17 | 2019-2022 | |
| Astellas Pharma US INC | $126.43 | 2022-2025 | Veozah |
| Lilly USA, LLC | $87.49 | 2023-2025 | Zepbound, Jardiance |
| Hologic Sales and Service, LLC | $79.15 | 2021-2023 | Thinprep 2000 Processor, Aptima, Novasure |
| Sage Therapeutics, LLC | $74.68 | 2024-2025 | Zurzuvae |
| Shield Therapeutics INC | $35.67 | 2023 | Accrufer |
| Axsome Therapeutics, INC. | $35.35 | 2023 | Auvelity |
| Minerva Surgical, INC | $26.25 | 2022-2024 | |
| Abbott Laboratories | $24.92 | 2023 | Freestyle Libre 3 |
| Channel Medsystems, INC. | $24.02 | 2022 | |
| Optumhealth Care Solutions, LLC | $21.26 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Coopersurgical, INC. | $20.81 | 2024 | Paragard T 380a |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $18.69 | 2025 | Evenity |
| Aspira Women'S Health INC | $17.87 | 2024 | Ova1 |
| Organon LLC | $17.02 | 2023 | Nexplanon |
| Smith+Nephew, INC. | $16.50 | 2024 | Stravix |
| Sunovion Pharmaceuticals INC. | $15.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Tucker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.